Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs.
Keystone Symposium: Dendritic Cells and Macrophages Reunited
Episode 20 with Dr. Jeffrey Cohen discussing two MS-related clinical trials
MS clinical trials: what can subgroup analyses teach us?
The role of natural killer cells in multiple sclerosis and their therapeutic implications.
Delayed visual evoked response in optic neuritis.
Episode 12 with Professor Gavin Giovannoni on the potential for finding a cure for MS.
Episode 18 with Dr. Samuel Ludwin on new approaches to remyelination therapies.
17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice.
Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration.
Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity.
Episode 7 with Dr. Daniel Kantor on access to care
Characterisation of microglia during de- and remyelination: can they create a repair promoting environment?
46th Annual WCBR Winter Conference on Brain Research
The force awakens: insights into the origin and formation of microglia.
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.
Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain.
Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study.
Spectrophotometric Determination of Serum Copper with Biscyclohexanoneoxalyldihydrazone
Neuroprotection in a novel mouse model of multiple sclerosis.
US and EU regulatory authorities accept oral BG-12 marketing applications for review
Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
ForuMS: A Virtual Journal Club for MS Clinicians
Request for Applications for Collaborative Network Awards from the Progressive MS Alliance
Pages
« first
‹ previous
…
54
55
56
57
58
59
60
61
62
…
next ›
last »